VEGF Correlates with Inflammation and Fibrosis in Tuberculous Pleural Effusion

Table 1

Demographic and clinical data of the patients studied.

	All patients	Loculated TBPE	Nonloculated TBPE	value^†
	( = 42)	( = 26)	( = 16)
Male, (%)	27 (64)	18 (69)	9 (56)	0.511
Age, yrs, mean ± SD	62 ± 21	61 ± 22	63 ± 21	0.824
Patients with comorbidities, (%)^*	28 (67)	18 (70)	10 (63)	0.742
Symptom onset to treatment, days, median (range)	10 (7–19)	10 (8–20)	10 (6–16)	0.547
Side of pleural effusion
Right/left, (%)	27/15 (64/36)	17/9 (65/35)	10/6 (63/37)	0.733

TBPE: uncomplicated parapneumonic effusion.
^*Comorbidities including alcoholism, diabetes mellitus, neurologic, cardiac, respiratory, liver, and kidney diseases.
^†For comparisons between loculated and nonloculated TBPE groups.